Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2008-A00330-55 | Other Identifier | Afssaps |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Foundation for the Future, Paris, France | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to test the efficacy of the Functionnal ElectromyoStimulation (FES) of lower limbs in advanced chronic heart failure. The hypothesis is that FES treatment could improve functional exercise capacity.
Advanced Chronic Heart Failure (ACHF) is a severe and frequent disease inducing a strong limitation of exercise capacity and a poor quality of life. Hospitalisation for cardiac decompensation is frequent and could alter their incapacities because of muscular deconditionning. Tradionnal aerobic rehabilitation exercises fighting against this deconditionning are not relevant in these patients because of dyspnea.
In litterature, Functionnal Electrostimulation (FES) has been tested in stable Chronic Heart Failure (NYHA I to III), far from decompensation. Several authors showed the same improvements than those obtained with conventionnal rehabilitation on aerobic capacities (peak VO2, 6 minutes walking test) and quality of life.
The originality of this study is to test FES soon after acute heart decompensation in ACHF patients. This type of rehabilitation could represent in the future an alternative to conventionnal rehabilitation until the patients could be able to do aerobic exercise.
60 patients will be randomised between two groups, the firsth receiving FES (treatment group), the second receiving skin electrostimulation in the same place without muscular contraction (Sham group). Patient and evaluator do not know what type of stimulation they have. These treatments spread over six weeks, five days per seven. They are began in rehabilitation unit then continued at home.
The principal criteria of judgement of FES efficacy is peak VO2 after the protocol. Secondary criteria are distance to the six minutes walking test, muscular strengh of quadriceps, the muscle mass measured by Dual energy X-ray absorptiometry (DEXA), inflamatory dosage (TNF alpha, IL-1, IL-6, CRP), rest value of Muscle sympathetic nerve activity, score to Minnesota questionnaire and fuctionnal independance.
The attempted results are an significative improvement of aerobic capacity(peak VO2 and six minutes walking test) and the others secondary criteria in FES group compared with Sham group.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Functionnal ElectroStimulation (FES) | Experimental |
| |
| SHAM | Sham Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Functionnal ElectroStimulation (FES) | Other | Functionnal ElectroStimulation on lower limbs, 1h per day, 5 days per 7, during 6 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| VO2 peak | change between baseline and 60 days after the Functional Electromyo Stimulation |
| Measure | Description | Time Frame |
|---|---|---|
| Muscle nerve sympathetic activity (MSNA) | change between baseline and 60 days after the Functional Electromyo Stimulation | |
| Six minutes walking test | change between baseline and 60 days after the Functional Electromyo Stimulation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michel GALINIER, MD, PhD | University Hospital, Toulouse | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Universty Hospital Toulouse Cardiology | Toulouse | 31059 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 24265770 | Result | Labrunee M, Despas F, Marque P, Guiraud T, Galinier M, Senard JM, Pathak A. Acute electromyostimulation decreases muscle sympathetic nerve activity in patients with advanced chronic heart failure (EMSICA Study). PLoS One. 2013 Nov 12;8(11):e79438. doi: 10.1371/journal.pone.0079438. eCollection 2013. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| SHAM | Other | SHAM on lower limbs, 1h per day, 5 days per 7, during 6 weeks |
|
| DEXA | change between baseline and 60 days after the Functional Electromyo Stimulation |
| maximal quadriceps strengh | change between baseline and 60 days after the Functional Electromyo Stimulation |
| interleukin 1 | change between baseline and 60 days after the Functional Electromyo Stimulation |
| interleukin 6 | change between baseline and 60 days after the Functional Electromyo Stimulation |
| TNF alpha | change between baseline and 60 days after the Functional Electromyo Stimulation |
| CRP | change between baseline and 60 days after the Functional Electromyo Stimulation |
| BNP | change between baseline and 60 days after the Functional Electromyo Stimulation |
| score of minessota test | change between baseline and 60 days after the Functional Electromyo Stimulation |
| score of Functional independency measure | change between baseline and 60 days after the Functional Electromyo Stimulation |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| C005703 | salicylhydroxamic acid |
Not provided
Not provided
Not provided